Massachusetts General Hospital: Metabolic Syndrome trials

The registry lists 14 Metabolic Syndrome studies with Massachusetts General Hospital as lead sponsor. 0 are open to participants now and 5 have results posted.

Phase 1 1Phase 2 1No phase 12(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• PREMIER: PREvention of Metabolic Illness Through prEcision nutRitionCompletedNCT04148482Not applicableResults posted
• Developing a Positive Psychology Intervention to Promote Health Behaviors in Metabolic Syndrome: Proof-of Concept TrialCompletedNCT03473886Not applicableResults posted
• Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and PsoriasisTerminatedNCT00477191Not applicableResults posted
• Study of TNF-Antagonism in the Metabolic Syndrome (II)CompletedNCT00413400Not applicableResults posted
• Lifestyle Modification and Metformin Use in the Treatment of HIVCompletedNCT00399360Not applicableResults posted
• Weekly Family Food Packages: Food is MedicineCompletedNCT05640414Not applicable
• Developing a Positive Psychology Intervention to Promote Health Behaviors in Metabolic Syndrome: RCTStatus unknownNCT04039165Not applicable
• Motivation-Audit-Positive Psychology Intervention StudyCompletedNCT03160755
• Neck Fat Accumulation and Its Relationship to Cardiovascular Risk and Metabolic SyndromeCompletedNCT02205021
• Cross-Sectional Iloperidone IVGTTCompletedNCT01686815
• Risks for Insulin Resistance and Metabolic Syndrome Between Major Depressive Disorder (MDD) or MDD With Psychotic FeaturesTerminatedNCT01310140
• Genetic Counseling and Lifestyle Change for Diabetes PreventionStatus unknownNCT01034319Phase 2
• Effect of Increasing Testosterone on Insulin Sensitivity in Men With the Metabolic SyndromeTerminatedNCT00438321Phase 1
• Study of TNF-Antagonism in Metabolic SyndromeCompletedNCT00409318Not applicable